Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

David F McDermott; Mahrukh A Huseni; Michael B Atkins; Robert J Motzer; Brian I Rini; Bernard Escudier; Lawrence Fong; Richard W Joseph; Sumanta K Pal; James A Reeves; Mario Sznol; John Hainsworth; W Kimryn Rathmell; Walter M Stadler; Thomas Hutson; Martin E Gore; Alain Ravaud; Sergio Bracarda; Cristina Suárez; Riccardo Danielli; Viktor Gruenwald; Toni K Choueiri; Dorothee Nickles; Suchit Jhunjhunwala; Elisabeth Piault-Louis; Alpa Thobhani; Jiaheng Qiu; Daniel S Chen; Priti S Hegde; Christina Schiff; Gregg D Fine; Thomas Powles

doi:10.1038/s41591-018-0235-z

Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

Nat Med. 2018 Dec;24(12):1941. doi: 10.1038/s41591-018-0235-z.

Authors

David F McDermott¹, Mahrukh A Huseni², Michael B Atkins³, Robert J Motzer⁴, Brian I Rini⁵, Bernard Escudier⁶, Lawrence Fong⁷, Richard W Joseph⁸, Sumanta K Pal⁹, James A Reeves¹⁰, Mario Sznol¹¹, John Hainsworth¹², W Kimryn Rathmell¹³, Walter M Stadler¹⁴, Thomas Hutson¹⁵, Martin E Gore¹⁶, Alain Ravaud¹⁷, Sergio Bracarda¹⁸, Cristina Suárez¹⁹, Riccardo Danielli²⁰, Viktor Gruenwald²¹, Toni K Choueiri²², Dorothee Nickles², Suchit Jhunjhunwala², Elisabeth Piault-Louis², Alpa Thobhani²³, Jiaheng Qiu², Daniel S Chen², Priti S Hegde², Christina Schiff², Gregg D Fine², Thomas Powles²⁴

Affiliations

¹ Beth Israel Deaconess Medical Center, Boston, MA, USA. dmcdermo@bidmc.harvard.edu.
² Genentech, Inc., South San Francisco, CA, USA.
³ Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA.
⁴ Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁵ Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
⁶ Gustave Roussy, Villejuif, France.
⁷ University of California, San Francisco School of Medicine, San Francisco, CA, USA.
⁸ Mayo Clinic Hospital -Florida, Jacksonville, FL, USA.
⁹ City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
¹⁰ Florida Cancer Specialists, Fort Myers, FL, USA.
¹¹ Yale School of Medicine, New Haven, CT, USA.
¹² Sarah Cannon Research Institute, Nashville, TN, USA.
¹³ Vanderbilt University Medical Center, Nashville, TN, USA.
¹⁴ University of Chicago Medicine, Chicago, IL, USA.
¹⁵ Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, TX, USA.
¹⁶ Royal Marsden Hospital, London, UK.
¹⁷ CHU Hopitaux de Bordeaux - Hôpital Saint-André, Bordeaux, France.
¹⁸ Ospedale San Donato, Azienda USL Toscana Sudest, Arezzo, Italy.
¹⁹ Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.
²⁰ Azienda Ospedaliera Universitaria Senese, Center for Immune-Oncology, Siena, Italy.
²¹ Medizinische Hochschule, Zentrum Innere Medizin, Abt. Hämatologie u. Onkologie, Hannover, Germany.
²² Dana-Farber Cancer Institute, Boston, MA, USA.
²³ Roche Products Ltd, Welwyn Garden City, UK.
²⁴ Barts Cancer Institute and the Royal Free Hospital, Queen Mary University of London, London, UK.

PMID: 30291359
DOI: 10.1038/s41591-018-0235-z

Abstract

In the version of this article originally published, there was an error in Fig. 2n. The top line of the HR comparison chart originally was Atezo + bev vs sun. It should have been Atezo + bev vs atezo. The error has been corrected in the HTML and PDF versions of this article.

Publication types

Published Erratum